Kolibaba, KS, Druker BJ. Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology-Oncology eJournal 3(2), 2000]. Available at ...

For chronic myeloid leukemia (CML) patients, there is a promising new first-line drug approval with asciminib (brand name ...

Targeted therapy revolutionized cancer treatment, with gene fusions leading the way when the FDA approved imatinib in 2001 to ...

“Portland had a much more entrepreneurial, pioneering spirit,” he says. “It was, yes, that makes sense. Let’s give that a try ...

In addition to developing WU-CART-007, a drug candidate in clinical trials for treating relapsed or refractory T-cell acute ...

According to Cullman County District Attorney Champ Crocker, district attorney’s offices are funded on a deficit, meaning ...

CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

The World Health Organization has defined chronic disease as non-communicable diseases enduring for long durations (five-year ...